Optimization Of Cancer Treatment Through Overcoming Drug Resistance

Yahya I Elshimali^{1

2}, Yong Wu^{1

2}, Hussein Khaddour^{3

4}, Yanyuan Wu^{1

2}, Daniela Gradinaru⁴, Hema Sukhija¹, Seyung S Chung^{1

2}, Jaydutt V Vadgama^{1

2}

Affiliations

¹ Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, USA.
² David Geffen School of Medicine at UCLA, UCLA's Jonsson Comprehensive Cancer Center, USA.
³ Faculty of Pharmacy, Mazzeh (17th April Street), Damascus University, Damascus, Syria.
⁴ Carol Davila - University of Medicine and Pharmacy, Faculty of Pharmacy, Department of Biochemistry, Romania.

PMID: 29932172
PMCID: PMC6007995
DOI: 10.31021/jcro.20181107

Optimization Of Cancer Treatment Through Overcoming Drug Resistance

Yahya I Elshimali et al. J Cancer Res Oncobiol. 2018.

. 2018;1(2):107.

doi: 10.31021/jcro.20181107. Epub 2018 Feb 27.

Authors

Yahya I Elshimali^{1

2}, Yong Wu^{1

2}, Hussein Khaddour^{3

4}, Yanyuan Wu^{1

2}, Daniela Gradinaru⁴, Hema Sukhija¹, Seyung S Chung^{1

2}, Jaydutt V Vadgama^{1

2}

Affiliations

¹ Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, USA.
² David Geffen School of Medicine at UCLA, UCLA's Jonsson Comprehensive Cancer Center, USA.
³ Faculty of Pharmacy, Mazzeh (17th April Street), Damascus University, Damascus, Syria.
⁴ Carol Davila - University of Medicine and Pharmacy, Faculty of Pharmacy, Department of Biochemistry, Romania.

PMID: 29932172
PMCID: PMC6007995
DOI: 10.31021/jcro.20181107

Abstract

Cancer Drug resistance is a medical concern that requires extensive research and a thorough understanding in order to overcome. Remarkable achievements related to this field have been accomplished and further work is needed in order to optimize the cure for cancer and serve as the basis for precise medicine with few or no side effects.

Keywords: Drug resistance; Malignancies; Molecular base; Optimal treatment.

PubMed Disclaimer

Cited by

Roles and regulatory mechanisms of KIN17 in cancers (Review).
Huang X, Dai Z, Li Q, Lin X, Huang Q, Zeng T. Huang X, et al. Oncol Lett. 2023 Feb 17;25(4):137. doi: 10.3892/ol.2023.13723. eCollection 2023 Apr. Oncol Lett. 2023. PMID: 36909374 Free PMC article. Review.
Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways.
Ashrafizadeh M, Zarrabi A, Saberifar S, Hashemi F, Hushmandi K, Hashemi F, Moghadam ER, Mohammadinejad R, Najafi M, Garg M. Ashrafizadeh M, et al. Biomedicines. 2020 May 5;8(5):110. doi: 10.3390/biomedicines8050110. Biomedicines. 2020. PMID: 32380783 Free PMC article. Review.
PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer.
Chen Y, Jia Y, Mao M, Gu Y, Xu C, Yang J, Hu W, Shen J, Hu D, Chen C, Li Z, Chen L, Ruan J, Shen P, Zhou J, Wei Q, Wang L. Chen Y, et al. J Cell Mol Med. 2021 Jul;25(14):6948-6962. doi: 10.1111/jcmm.16706. Epub 2021 Jun 11. J Cell Mol Med. 2021. PMID: 34117724 Free PMC article.
Chromatin remodeling-driven autophagy activation induces cisplatin resistance in oral squamous cell carcinoma.
Oh SY, Kim J, Lee KY, Lee HJ, Kwon TG, Kim JW, Lee ST, Kim DG, Choi SY, Hong SH. Oh SY, et al. Cell Death Dis. 2024 Aug 13;15(8):589. doi: 10.1038/s41419-024-06975-1. Cell Death Dis. 2024. PMID: 39138148 Free PMC article.
Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets.
Dräger O, Metz K, Busch M, Dünker N. Dräger O, et al. Mol Oncol. 2022 Feb;16(4):957-981. doi: 10.1002/1878-0261.13054. Epub 2021 Jul 18. Mol Oncol. 2022. PMID: 34228897 Free PMC article.

See all "Cited by" articles

References

1. Fiaschi T, Chiarugi P. Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison. J Cell Biol. 2012 Mar;:762825. - PMC - PubMed
1. Alisi A, Cho WC, Locatelli F, Fruci D. Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma. Int J Mol Sci. 2013 Dec;14(12):24706–24725. - PMC - PubMed
1. Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002;53:615–627. - PubMed
1. Evolution of cancer treatments: Chemotherapy. http://www.cancer.org/cancer/cancerbasics/thehistoryofcancer/the-history....
1. Luqmani YA. Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract. 2005;14(Suppl 1):35–48. - PubMed

Grants and funding

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Optimization Of Cancer Treatment Through Overcoming Drug Resistance

Affiliations

Optimization Of Cancer Treatment Through Overcoming Drug Resistance

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources